http://researchonline.federation.edu.au/vital/access/manager/Index ${session.getAttribute("locale")} 5 TIMP-2 regulates proliferation, invasion and STAT3-mediated cancer stem cell-dependent chemoresistance in ovarian cancer cells http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:14820 Wed 25 Nov 2020 14:15:41 AEDT ]]> In vitro and in vivo toxicity and biodistribution of paclitaxel-loaded cubosomes as a drug delivery nanocarrier : a case study using an A431 skin cancer xenograft model http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:14750 Wed 07 Apr 2021 14:02:50 AEST ]]> Ovarian cancer, cancer stem cells and current treatment strategies : a potential role of magmas in the current treatment methods http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:14469 Wed 07 Apr 2021 14:02:33 AEST ]]> Paclitaxel-induced Src activation is inhibited by dasatinib treatment, independently of cancer stem cell properties, in a mouse model of ovarian cancer http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:13849 Wed 07 Apr 2021 14:01:57 AEST ]]> Paclitaxel-loaded self-assembled lipid nanoparticles as targeted drug delivery systems for the treatment of aggressive ovarian cancer http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:13715 Wed 07 Apr 2021 14:01:49 AEST ]]> Tumour microenvironment and metabolic plasticity in cancer and cancer stem cells : Perspectives on metabolic and immune regulatory signatures in chemoresistant ovarian cancer stem cells http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:13504 Wed 07 Apr 2021 14:01:38 AEST ]]> Momelotinib decreased cancer stem cell associated tumor burden and prolonged disease-free remission period in a mouse model of human ovarian cancer http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:13084 Wed 07 Apr 2021 14:01:16 AEST ]]> The many facets of metzincins and their endogenous inhibitors : Perspectives on ovarian cancer progression http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:13055 Wed 07 Apr 2021 14:01:15 AEST ]]> Knockdown of stem cell regulator Oct4A in ovarian cancer reveals cellular reprogramming associated with key regulators of cytoskeleton-extracellular matrix remodelling http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:11406 Wed 07 Apr 2021 13:56:43 AEST ]]> Coalition of Oct4A and β1 integrins in facilitating metastasis in ovarian cancer http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:10794 Wed 07 Apr 2021 13:56:09 AEST ]]> Unique proteome signature of post-chemotherapy ovarian cancer ascites-derived tumor cells http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:10784 Wed 07 Apr 2021 13:56:08 AEST ]]> In vitro and in silico analysis of epithelial-mesenchymal transition and cancer stemness as prognostic markers of clear cell renal cell carcinoma http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:18577 Tue 14 Nov 2023 12:06:18 AEDT ]]> Precision medicine : an optimal approach to patient care in renal cell carcinoma http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:17462 Thu 23 Mar 2023 11:48:07 AEDT ]]> Platinum-resistance in epithelial ovarian cancer: an interplay of epithelial–mesenchymal transition interlinked with reprogrammed metabolism http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:17967 Thu 22 Jun 2023 13:21:23 AEST ]]> Expression of TIMPs and MMPs in ovarian tumors, ascites, ascites-derived cells, and cancer cell lines : characteristic modulatory response before and after chemotherapy treatment http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:16913 Thu 01 Dec 2022 11:58:10 AEDT ]]> The attributes of plakins in cancer and disease: perspectives on ovarian cancer progression, chemoresistance and recurrence http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:15336 Mon 25 Oct 2021 11:55:11 AEDT ]]> Knock down of TIMP-2 by siRNA and CRISPR/Cas9 mediates diverse cellular reprogramming of metastasis and chemosensitivity in ovarian cancer http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:17730 Mon 15 May 2023 11:18:12 AEST ]]> Determinants of resistance to VEGF-TKI and immune checkpoint inhibitors in metastatic renal cell carcinoma http://researchonline.federation.edu.au/vital/access/manager/Repository/vital:15520 Mon 13 Dec 2021 15:39:11 AEDT ]]>